about
Effects of topiramate on ethanol-cocaine interactions and DNA methyltransferase gene expression in the rat prefrontal cortexA spontaneous deletion of α-synuclein is associated with an increase in CB1 mRNA transcript and receptor expression in the hippocampus and amygdala: effects on alcohol consumption.The genetic basis of the endocannabinoid system and drug addiction in humans.Common single nucleotide variants underlying drug addiction: more than a decade of research.The CB1 receptor is required for the establishment of the hyperlocomotor phenotype in developmentally-induced hypothyroidism in mice.Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.Histone Deacetylase Gene Expression Following Binge Alcohol Consumption in Rats and Humans.Nalmefene is effective at reducing alcohol seeking, treating alcohol-cocaine interactions and reducing alcohol-induced histone deacetylases gene expression in blood.Developmentally-induced hypothyroidism alters the expression of Egr-1 and Arc genes and the sensitivity to cannabinoid agonists in the hippocampus. Possible implications for memory and learning.C957T polymorphism of the dopamine D2 receptor gene is associated with motor learning and heart rate.Phosphodiesterase7 Inhibition Activates Adult Neurogenesis in Hippocampus and Subventricular Zone In Vitro and In Vivo.Cocaine reverses the naltrexone-induced reduction in operant ethanol self-administration: the effects on immediate-early gene expression in the rat prefrontal cortex.Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain.Risky alcohol consumption in young people is associated with the fatty acid amide hydrolase gene polymorphism C385A and affective rating of drug pictures.Is R(+)-Baclofen the best option for the future of Baclofen in alcohol dependence pharmacotherapy? Insights from the preclinical sideLow Phytanic Acid-Concentrated DHA Prevents Cognitive Deficit and Regulates Alzheimer Disease Mediators in an ApoE-/- Mice Experimental Model
P50
Q28581552-06B61725-17A3-47AE-B2B2-6444294BAD4AQ37597181-3EE5F5CA-7802-47D9-990F-3AD7984B0EDCQ37936694-F7E62139-B86E-497B-BB78-EAAABE764D79Q38325368-B040A34A-4785-44D6-92E4-B89233011296Q39065504-DC8518AB-78F9-470F-BD77-078356D1515CQ39171180-0C826E95-6B77-4CEF-8561-D9F11E54B2FDQ40544218-58BA2C8F-4E10-4D14-82FC-8DD83EA05A3FQ42406039-2A356E3F-C2F2-42C7-9E0F-E396E0E43B4CQ42514431-60D7AB7A-281F-4557-ACA8-8EA0445B98CDQ43429696-082CEB7D-16FC-405B-BF50-D0749FDC8E3EQ48105573-C7CB9DE7-BB5C-4CDE-B11B-E82BFD4B6C17Q48150436-000881A6-AB83-42B8-9688-361FD455A058Q48242010-2C25C2D1-782C-49D9-B260-80CC767D9A97Q52303845-09B797A8-9D57-444A-AEC2-26695ED07C1BQ90134905-4FDDF534-3499-476B-B263-A126951D27B6Q90706367-56E4546F-4308-4D00-B803-D3170D808D8B
P50
description
investigador
@es
researcher
@en
name
V Echeverry-Alzate
@en
type
label
V Echeverry-Alzate
@en
prefLabel
V Echeverry-Alzate
@en
P31
P496
0000-0001-9059-3513